tbuckley/cabot-search huggingface dataset:
Controversies in Management: Psychological treatment is essential for some
Authors: F. Creed
Journal: BMJ (1994)

Strong evidence exists that the irritable bowel syndrome has an important psychological component. Firstly, about half of patients with the irritable bowel syndrome in a hospital clinic have psychiatric disorder when assessed by research criteria.1 This is two or three times greater than the prevalence among patients with organic gastrointestinal conditions such as peptic ulcers or inflammatory bowel disturbance and healthy controls (<20%),1 suggesting a strong association between the irritable bowel syndrome and psychological disorder. Although anxiety, depression, and sexual problems might be the consequence of persistent abdominal symptoms, they are not found to the same extent in patients with organic diseases that also lead to persistent abdominal symptoms.2 The anxiety and depression might explain attendance at the hospital rather than the occurrence of the symptoms,3 4 but people attending hospital also have much worse intestinal symptoms than people with the irritable bowel syndrome in the community, and the anxiety almost certainly exacerbates the pain and bowel dysfunction.5

Secondly, two thirds of patients with the irritable bowel syndrome have experienced a severe social stress such as bereavement, marital separation, or major argument leading to a broken family relationship before the onset of the abdominal symptoms. This compares with about a quarter of patients with organic …
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction As a Developmental Susceptibility to ETV6-RUNX1
Authors: Simon E Richardson, Charlotta Boiers, Alya Zriwil, Emma Laycock, Virginia A Turati, John Brown, Jason Wray, Chela James, Dapeng Wang, Javier Herrero, Ewa Sitnicka, Stefan Karlsson, Andrew J.H. Smith, Sten Eirik Jacobsen, Tariq Enver
Journal: Blood (2017)
MA15.09 PD-L1 Status in Relation with Non-Small Cell Lung Cancer Major Subtypes, Differentiation, Molecular Profiling and Smoking History
Authors: A. Surette, M. Castonguay, D. Bethune, A. Drucker, D. French, H. Henteleff, M. Macneil, W. Morzycki, M. Plourde, S. Snow, Z. Xu
Journal: Journal of Thoracic Oncology (2019)
Asymptomatic Metastasis to Thyroid Cartilage Detected by 18F-Choline and 64Cu-PSMA PET/CT as a Single Site of Disease Relapse in a Patient With Castration-Resistant Prostate Carcinoma
Authors: Alessio Annovazzi, Adriana Faiella, Edoardo Pescarmona, Giuseppe Sanguineti, Rosa Sciuto
Journal: Clinical Nuclear Medicine (2019)

Metastatic involvement of the larynx is rare due to the absence of vessels within the cartilaginous tissue. The probability of metastatic spread increases with aging as a result of larynx ossification. The secondary involvement of larynx is more frequently associated with melanoma and renal cell carcinoma. Few observations have been reported also in prostate cancer patients, usually associated with advanced disease and diffuse metastatic bone involvement. We report a case of an 83-year-old man with castration-resistant prostate cancer in whom a metastasis to the thyroid cartilage was the only site of relapse.
MA17.07 Identification of AHR as a Novel Regulator of Lung Cancer Metastasis
Authors: S. Nothdurft, F. Breitenbuecher, R. Okimoto, T. Bivona, B. Gruener, M. Hoelzel, J. Forster, S. Kalmbach, A. Schramm, M. Schuler
Journal: Journal of Thoracic Oncology (2019)
EP1.12-26 Retrospective Study About the Impact of Brain Metastases and Cranial Irradiation in Small Cell Lung Cancer
Authors: D. Sanchez Cabrero, P. Cruz, S. Martinez, P. Perez, A. Pertejo, O. Higuera, L. Gutierrez, J. Villamayor, D. Viñal, I. Esteban, J.L. Torres, J. Ramón, J. De Castro Carpeno
Journal: Journal of Thoracic Oncology (2019)
P1.03-16 Anti-Tumor Effect of Pan-RAF Inhibitor in NSCLC Cells Harboring BRAF Mutation
Authors: S. Miyauchi, K. Shien, K. Araki, K. Nakata, A. Miura, K. Namba, K. Suzawa, H. Yamamoto, M. Okazaki, S. Tomida, S. Toyooka
Journal: Journal of Thoracic Oncology (2019)
P1.11-03 Disparities and National Lung Cancer Screening Guidelines in the U.S. Population
Authors: S. Han, E. Chow, K. Ten Haaf, I. Toumazis, M. Bastani, M. Tammemägi, J. Jeon, E. Feuer, R. Meza, S. Plevritis
Journal: Journal of Thoracic Oncology (2019)
P2.01-103 Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Authors: M. Dersarkissian, R. Bhak, H. Lin, S. Li, M. Cheng, A. Lax, H. Huang, M. Duh, S. Ou
Journal: Journal of Thoracic Oncology (2019)
Soil domestication by rice cultivation results in plant-soil feedback through shifts in soil microbiota
Authors: Joseph Edwards, Christian Santos-Medellín, Bao Nguyen, John Kilmer, Zachary Liechty, Esteban Veliz, Jiadong Ni, Gregory Phillips, Venkatesan Sundaresan
Journal: Genome biology (2019)

Soils are a key component of agricultural productivity, and soil microbiota determine the availability of many essential plant nutrients. Agricultural domestication of soils, that is, the conversion of previously uncultivated soils to a cultivated state, is frequently accompanied by intensive monoculture, especially in the developing world. However, there is limited understanding of how continuous cultivation alters the structure of prokaryotic soil microbiota after soil domestication, including to what extent crop plants impact soil microbiota composition, and how changes in microbiota composition arising from cultivation affect crop performance.We show here that continuous monoculture (> 8 growing seasons) of the major food crop rice under flooded conditions is associated with a pronounced shift in soil bacterial and archaeal microbiota structure towards a more consistent composition, thereby domesticating microbiota of previously uncultivated sites. Aside from the potential effects of agricultural cultivation practices, we provide evidence that rice plants themselves are important drivers of the domestication process, acting through selective enrichment of specific taxa, including methanogenic archaea, in their rhizosphere that differ from those of native plants growing in the same environment. Furthermore, we find that microbiota from soils domesticated by rice cultivation contribute to plant-soil feedback, by imparting a negative effect on rice seedling vigor.Soil domestication through continuous monoculture cultivation of rice results in compositional changes in the soil microbiota, which are in part driven by the rice plants. The consequences include a negative impact on plant performance and increases in greenhouse gas emitting microbes.
P1.06-05 Clinical Features and Outcomes of Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma
Authors: A. Nakamura, M. Hashimoto, A. Kuroda, T. Nakamichi, S. Matsumoto, N. Kondo, T. Kijima, S. Hasegawa
Journal: Journal of Thoracic Oncology (2019)
Carcinoembryonic antigen carrying SLe<sup>X</sup> as a new biomarker of more aggressive gastric carcinomas
Authors: Catarina Gomes, Andreia Almeida, Ana Barreira, Juliana Calheiros, Filipe Pinto, Rafaela Abrantes, Ana Costa, António Polonia, Diana Campos, Hugo Osório, Hugo Sousa, João Pinto-de-Sousa, Daniel Kolarich, Celso A. Reis
Journal: Theranostics (2019)

Malignant transformation of gastric cells is accompanied by the deregulated expression of glycosyltransferases leading to the biosynthesis of tumor-associated glycans such as the sialyl-Lewis X antigen (SLe x ).SLe x presence on cell surface glycoconjugates increases the invasive capacity of gastric cancer cells and is associated with tumor metastasis.ST3Gal IV enzyme is involved in the synthesis of SLe x antigen and overexpressed in gastric carcinomas.Herein, we identified the glycoproteins carrying SLe x in gastric cancer cells overexpressing ST3Gal IV enzyme and evaluated their biomarker potential for gastric carcinoma.Methods: SLe x modified glycoproteins were identified applying western blot and mass spectrometry.Immunoprecipitation, proximity ligation assay (PLA), E-selectin binding assay and CRISPR/cas9 knockout experiments were performed to characterize the presence of SLe x on the identified glycoprotein.Protein N-glycans of the SLe x protein carrier were in deep analyzed by porous-graphitized-carbon liquid-chromatography and tandem mass spectrometry glycomics.In silico expression analysis of α2-3 sialyltransferase ST3Gal IV and SLe x protein carrier was performed and the conjoint expression of the SLe x modified glycoproteins evaluated by immunohistochemistry and PLA in a series of gastric carcinomas.Results: Carcinoembryonic antigen (CEA; CEACAM5) was identified and validated by different methodologies as a major carrier of SLe x .N-glycomics of CEA revealed that complex N-glycans are capped with α2-3 linked sialic acid (Neu5Acα2-3Galβ1-4GlcNAc). Data set analysis of ST3Gal IV and CEA showed that ST3Gal IV expression was associated with patient´s poor survival, whereas CEA did not show any prognostic value.The co-expression of both CEA and SLe X was observed in 86,3% of gastric carcinoma cases and 74,5% of the total cases displayed the conjoint CEA+SLe x in situ PLA expression.This expression was associated with clinicopathological features of the tumors, including infiltrative pattern of tumor growth, presence of venous invasion and patient's poor survival.CEA immunoprecipitation from gastric carcinoma tissues also confirmed the presence of SLe x .Conclusion: CEA is the major glycoprotein carrying SLe x in gastric carcinoma and the conjoint detection of CEA-SLe x is associated with aggressive tumor features highlighting its PLA detection as a biomarker of gastric cancer patient prognosis for theranostic applications.
P1.11-27 Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-Based Comparative Study
Authors: Y. Du, Q. Li, G. Sidorenkov, M. Vonder, J. Cai, G. De Bock, M. Rook, R. Vliegenthart, M. Heuvelmans, M. Dorrius, H. Groen, P. Der Harst, Z. Ye, X. Xie, W. Wang, M. Oudkerk, S. Liu
Journal: Journal of Thoracic Oncology (2019)
P2.17-05 Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
Authors: N. Katsurada, M. Tachihara, Y. Hatakeyama, K. Koyama, M. Yumura, T. Kiriu, R. Dokuni, D. Hazama, S. Tokunaga, D. Tamura, K. Nakata, M. Yamamoto, H. Kamiryo, K. Kobayashi, Y. Tanaka, Y. Maniwa, Y. Nishimura
Journal: Journal of Thoracic Oncology (2019)
MA12.10 Novel Germline Mutations in DNA-Damage Repair and DNA Replication Identified in Patients with Malignant Pleural Mesothelioma (MPM)
Authors: R. Guo, M. Duboff, M. Kris, M. Ladanyi, D. Mandelker, M. Zauderer
Journal: Journal of Thoracic Oncology (2019)
MA14.07 Phase I Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naïve Non-Small Cell Lung Cancer (JVDF)
Authors: R. Herbst, H. Arkenau, J. Bendell, E. Arrowsmith, M. Wermke, A. Soriano, N. Penel, R. Santana-Davila, H. Bischoff, I. Chau, B. Chao, D. Ferry, G. Mi, L. Paz-Ares
Journal: Journal of Thoracic Oncology (2019)
Molecular typing of cryoglobulins by mass spectrometry
Authors: Adrian YS Lee, Tim Chataway, Thomas P Gordon, Jing Jing Wang
Journal: Annals of the Rheumatic Diseases (2019)

A cause of potentially devastating pathologies, cryoglobulins are immunoglobulin complexes that precipitate out of serum at temperatures lower than 37°C. They often arise secondary to underlying conditions, such as hepatitis infections, although may be idiopathic. Brouet et al 1 classified cryoglobulins according to their immunoglobulin composition: type I (monoclonal), type II (mixed with monoclonal rheumatoid factor (RF)) and type III (mixed with polyclonal RF).

Detection of cryoglobulins has not changed in decades and as a multistep process, is fraught with problems and a lack of universal standardisation to preanalytic handling. Currently, electrophoresis and immunofixation methods are used to characterise cryoglobulins. These techniques are unable to resolve and track specific clonotypes which can mutate and change pathogenicity over time.

Mass spectrometry (MS) may be used to molecularly type IgM RFs in cryoglobulins.2 Using an MS-based proteomic approach, we recently identified the immunoglobulin heavy chain variable region (IGHV) subfamilies and mutational …
P2.14-46 Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
Authors: M.J. Hochmair, C. Weinlinger, H. Fabikan, O. Illini, D. Krenbek, U. Setinek, S. Watzka, R. Koger, M. Meilinger, G. Absenger, M. Wanke, C. Semmelweis, M. Rauter, A. Valipour
Journal: Journal of Thoracic Oncology (2019)
MA18.03 Distinction Between Primary Lung Cancer and Pulmonary Metastasis of Esophageal Cancer Using the Nanostring nCounter System
Authors: J. Ichinose, H. Ninomiya, H. Nagano, Y. Matsuura, M. Nakao, S. Okumura, M. Mun
Journal: Journal of Thoracic Oncology (2019)
18F-Fluorocholine PET/CT Imaging of Brown Tumors in a Patient With Severe Primary Hyperparathyroidism
Authors: Jules Zhang-Yin, Sébastien Gaujoux, Thierry Delbot, Mathieu Gauthé, Jean-Noël Talbot
Journal: Clinical Nuclear Medicine (2019)

Abstract Brown tumors are rare skeletal anomalies occurring in patients with hyperparathyroidism and exposing patients to pathological fractures. We report the case of a 26-year-old woman with severe primary hyperparathyroidism (calcemia, 2.9 mmol/L; parathyroid hormone, 59 pmol/L) who underwent 18 F-fluorocholine (FCH) PET/CT before parathyroidectomy. FCH PET localized the hyperfunctioning parathyroid gland and showed multiple foci in correspondence with bone lytic lesions on CT. Those lesions were not visible on the 99m Tc-MIBI dual-phase scintigraphy. The pathology of one of the FCH-positive bone lesions corresponded to a brown tumor related to hyperparathyroidism.
P1.12-06 Ozone-Primed Neutrophils Promote Early Steps of Tumor Cell Metastasis to Lungs by Enhancing Their NETs Production
Authors: N. Rocks, C. Vanwinge, C. Radermecker, S. Blacher, C. Gilles, R. Marée, A. Gillard, B. Evrard, C. Pequeux, T. Marichal, A. Noël, D. Cataldo
Journal: Journal of Thoracic Oncology (2019)
Economic evaluation of sunitinib versus other new targeted therapies as first-line treatment of metastatic renal cell carcinoma (mRCC) in the United States
Authors: A. Benedict, R. A. Figlin, C. Charbonneau, N. Kreif, S. Hariharan, S. Négrier
Journal: Journal of Clinical Oncology (2009)

e17556 Background: RCC, the most prevalent kidney cancer, is a relatively rare malignancy that carries a poor prognosis. New targeted therapies, such as sunitinib, sorafenib, temsirolimus, and bevacizumab + interferon-alfa (IFN-α), are now available in the US for the treatment of mRCC. In the absence of head-to-head trials, the aim of this analysis was to assess the economic value of these therapies as first-line treatment of mRCC from a U.S. third-party payer perspective, using an indirect comparison based on reported survival data. Methods: An economic model was built to simulate progression-free and overall survival based on each treatment's hazard ratio against IFN-α as reported from phase II and III clinical trials. Clinical model parameters were also derived from these trials and complemented with clinical experts’ opinions. Costs of drugs, routine follow-up, treatment-related adverse events, disease progression, and best supportive care of terminally-ill patients were included in the model. Results, expressed as life-years (LY), progression-free LY (PFLY), and quality adjusted LY (QALY) gained, treatment costs (applied in 2008 USD), and incremental cost-effectiveness ratios (ICER), were obtained through probabilistic analysis over a 10-year time horizon. Since the phase III clinical trial of temsirolimus included the MSKCC (modified) poor risk group patients only, two separate evaluations were carried out: (1) comparison of sunitinib, sorafenib, and bevacizumab + IFN-α in all patients and (2) a similar comparison of sunitinib and temsirolimus in the poor-risk group patients only. Results: In the first comparison model, sunitinib was both more effective (with gains of 0.52 and 0.19 PFLY, and 0.17 and 0.03 QALY) and less costly (by $13,675 and $84,260) than sorafenib and bevacizumab + IFN-α, respectively, over 10 years. Similarly, sunitinib was both more effective (with gains of 0.12 PFLY and 0.07 QALY) and less costly (saving $9,605 over ten years) than temsirolimus in patients in the poor risk group. Conclusions: These model results suggest that sunitinib is a cost-effective alternative to sorafenib, bevacizumab + IFN-α, and temsirolimus as a first-line treatment of mRCC. [Table: see text]
Response to: ‘Association between osteoporosis and statins therapy’ by Lai
Authors: Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer
Journal: Annals of the Rheumatic Diseases (2019)

We read with interest the correspondence of Lai .1 Whether statin therapy impacts the risk of osteoporosis is still a matter of debate. We have recently shown that there is a dose-dependent relationship between statins and diagnosis of osteoporosis; while low-dose statin treatment was related to an underrepresentation of diagnosed osteoporosis when compared with non-statin-treated patients, we found in patients on higher dosages of statins an overrepresentation of diagnosed osteoporosis in the general Austrian population.2 Although osteoporosis is often underdiagnosed until incident fractures, our data are based on diagnoses derived from in-patient treatment. Even though there are data available suggesting that some statins could have protective effects on osteoporosis,3 in the JUPITER trial, an international, randomised, double-blind and placebo-controlled study in which 17 802 patients were investigated, it has been shown that high-potency statin treatment did not reduce the risk of fractures.4 The fact that statin treatment might not only have positive …
Heart failure in Norway, 2000–2014: analysing incident, total and readmission rates using data from the Cardiovascular Disease in Norway (CVDNOR) Project
Authors: Gerhard Sulo, Jannicke Igland, Simon Øverland, Grace M. Egeland, Gregory A. Roth, Stein E. Vollset, Grethe S. Tell
Journal: European Journal of Heart Failure (2019)
A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study
Authors: Oleguer Plana-Ripoll, Carsten Bøcker Pedersen, Esben Agerbo, Yan Holtz, Annette Erlangsen, Vladimir Canudas-Romo, Per Kragh Andersen, Fiona J Charlson, Maria K Christensen, Holly E Erskine, Alize J Ferrari, Kim Moesgaard Iburg, Natalie Momen, Preben Bo Mortensen, Merete Nordentoft, Damian F Santomauro, James G Scott, Harvey A Whiteford, Nanna Weye, John J McGrath, Thomas M Laursen
Journal: The Lancet (2019)
P1.14-27 Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis
Authors: C. Baik, T. Patil, K. Kirtane, R. Santana-Davila, T. Rich, C. Espenschied, C. Weipert, S. Mach, K. Reckamp, R. Doebele
Journal: Journal of Thoracic Oncology (2019)
OA14.02 IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC
Authors: R. Jotte, F. Cappuzzo, I. Vynnychenko, D. Stroyakovskiy, D. Rodriguez Abreu, M. Hussein, R. Soo, H. Conter, T. Kozuki, K. Huang, V. Graupner, S. Sun, T. Hoang, H. Jessop, M. Mccleland, M. Ballinger, A. Sandler, M. Socinski
Journal: Journal of Thoracic Oncology (2019)
P1.18-07 Postoperative Complications and Long-Term Survival Among Octogenarians Treated Surgically for Non-Small Cell Lung Cancer
Authors: M. Shimomura, H. Tsunezuka, S. Okada, S. Ishihara, N. Ishikawa, S. Ikebe, T. Furuya, K. Kameyama, S. Kitaoka, J. Shimada, M. Inoue
Journal: Journal of Thoracic Oncology (2019)
P1.17-14 Prognostic Value of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer: A Meta-Analysis
Authors: S. Tuminello, R. Veluswamy, W. Lieberman-Cribbin, S. Gnjatic, F. Petralia, P. Wang, R. Flores, M. Van Gerwen
Journal: Journal of Thoracic Oncology (2019)
Inter-host Transmission of Carbapenemase-Producing <i>Escherichia coli</i> among Humans and Backyard Animals
Authors: Jiyun Li, Zhenwang Bi, Shizhen Ma, Baoli Chen, Chang Cai, Junjia He, Stefan Schwarz, Chengtao Sun, Yuqing Zhou, Jia Yin, Anette Hulth, Yongqiang Wang, Zhangqi Shen, Shaolin Wang, Congming Wu, Lennart E. Nilsson, Timothy R Walsh, Stefan Börjesson, Jianzhong Shen, Qiang Sun, Yang Wang
Journal: Environmental Health Perspectives (2019)

Background: The rapidly increasing dissemination of carbapenem-resistant Enterobacteriaceae (CRE) in both humans and animals poses a global threat to public health. However, the transmission of CRE between humans and animals has not yet been well studied. Objectives: We investigated the prevalence, risk factors, and drivers of CRE transmission between humans and their backyard animals in rural China. Methods: We conducted a comprehensive sampling strategy in 12 villages in Shandong, China. Using the household [residents and their backyard animals (farm and companion animals)] as a single surveillance unit, we assessed the prevalence of CRE at the household level and examined the factors associated with CRE carriage through a detailed questionnaire. Genetic relationships among human- and animal-derived CRE were assessed using whole-genome sequencing–based molecular methods. Results: A total of 88 New Delhi metallo-β-lactamases–type carbapenem-resistant Escherichia coli (NDM-EC), including 17 from humans, 44 from pigs, 12 from chickens, 1 from cattle, and 2 from dogs, were isolated from 65 of the 746 households examined. The remaining 12 NDM-EC were from flies in the immediate backyard environment. The NDM-EC colonization in households was significantly associated with a) the number of species of backyard animals raised/kept in the same household, and b) the use of human and/or animal feces as fertilizer. Discriminant analysis of principal components (DAPC) revealed that a large proportion of the core genomes of the NDM-EC belonged to strains from hosts other than their own, and several human isolates shared closely related core single-nucleotide polymorphisms and blaNDM genetic contexts with isolates from backyard animals. Conclusions: To our knowledge, we are the first to report evidence of direct transmission of NDM-EC between humans and animals. Given the rise of NDM-EC in community and hospital infections, combating NDM-EC transmission in backyard farm systems is needed. https://doi.org/10.1289/EHP5251
P1.01-06 Comparative Effectiveness of First Line (1L) Therapies for Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)
Authors: S. Goring, T. Li, A. Gara, N. Varol, B. Korytowsky, N. Hertel, P. Baas
Journal: Journal of Thoracic Oncology (2019)
P2.04-49 Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
Authors: L. Landi, L. Bonanno, A. Delmonte, M. Papi, V. Stati, V. Minotti, C. Bennati, F. D'Incà, M. Migliorino, S. Gori, A. Santo, F. Piantedosi, A. Russo, F. Cappuzzo
Journal: Journal of Thoracic Oncology (2019)
P1.04-54 Inter-Tumor Heterogeneity of PD-L1 Expressions in Non-Small Cell Lung Cancer
Authors: Y. Saito, S. Horiuchi, H. Morooka, T. Ibi, N. Takahashi, T. Ikeya, E. Hoshi, Y. Shimizu
Journal: Journal of Thoracic Oncology (2019)
Northern Ireland woman is acquitted of buying abortion pills online
Authors: Clare Dyer
Journal: BMJ (2019)

A woman in Northern Ireland who was prosecuted for buying abortion pills over the internet for her 15 year old daughter has been formally acquitted at Belfast Crown Court, a day after abortion was decriminalised in the province.

Judge David McFarland directed a jury to find the woman not guilty after the prosecution offered no evidence. She had been reported to …
P1.16-48 Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts
Authors: I. Elkins, R. Bordoni, R. Shenolikar, A. Ryden, M. Martin, N. Bakker, H. Chung, J. Feldman
Journal: Journal of Thoracic Oncology (2019)